LPL Financial
ARIA

LPL Financial’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

LPL Financial’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-20,582
Closed -$134K – 3191
2016
Q1 		$134K Sell
20,582
-600
-3% -$3.36K ﹤0.01% 2896
2015
Q4 		$128K Buy
+21,182
New +$139K ﹤0.01% 2945
2015
Q3 		– Sell
-11,669
Closed -$93K – 2957
2015
Q2 		$93K Sell
11,669
-1,000
-8% -$8.84K ﹤0.01% 2759
2015
Q1 		$103K Sell
12,669
-4,741
-27% -$35K ﹤0.01% 2673
2014
Q4 		$120K Sell
17,410
-64,600
-79% -$404K ﹤0.01% 2607
2014
Q3 		$433K Buy
82,010
+47,719
+139% +$279K ﹤0.01% 1901
2014
Q2 		$218K Sell
34,291
-2,231
-6% -$15.3K ﹤0.01% 2425
2014
Q1 		$294K Sell
36,522
-11,233
-24% -$87.5K ﹤0.01% 2137
2013
Q4 		$326K Buy
47,755
+35,893
+303% +$194K ﹤0.01% 2054
2013
Q3 		$50K Sell
11,862
-975
-8% -$18.9K ﹤0.01% 2492
2013
Q2 		$225K Buy
+12,837
New +$228K ﹤0.01% 2117

Other funds holding ARIA

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

LPL Financial's ARIA Position: Q2 2016 in Review

LPL Financial sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2016, closing a stake of 20,582 shares — an estimated $134K sold.

LPL Financial first reported a position in ARIA in Q2 2013 and held it in 11 quarters. The position peaked at $433K in Q3 2014. 182 funds tracked by Wall St. Rank hold ARIA as of Q2 2016.

  • LPL Financial reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2016 after selling out during the quarter.
  • LPL Financial sold 20,582 Ariad Pharmaceuticals Inc shares in Q2 2016, an estimated $134K.
  • LPL Financial first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 11 quarters.
  • LPL Financial's Ariad Pharmaceuticals Inc position peaked at $433K in Q3 2014.
  • 182 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2016.

Based on LPL Financial's 13F filing for Q2 2016, filed 15 Aug 2016.